852227-97-5

Basic information

• Product Name: 1-[3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]PIPERIDINE
• Synonyms: 1-[3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]PIPERIDINE;3-(Piperidin-1-yl)benzeneboronic acid, pinacol ester;3-Piperidinophenylboronic acid, pinacol ester
• CAS NO: 852227-97-5
• Molecular Formula: C₁₇H₂₆BNO₂
• Molecular Weight: 287.2
• Mol File: 852227-97-5.mol
• Article Data: 3

Chemical Properties

• Melting Point: 156 °C
• Boiling Point: 419.4°C at 760 mmHg
• Flash Point: 207.5°C
• Appearance: /
• Density: 1.04g/cm³
• Vapor Pressure: 3.04E-07mmHg at 25°C
• Refractive Index: 1.528
• Storage Temp.: 2-8°C
• PKA: 5.47±0.40(Predicted)
• CAS DataBase Reference: 1-[3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]PIPERIDINE(852227-97-5)
• EPA Substance Registry System: 1-[3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]PIPERIDINE(852227-97-5)

Safety Data

• Hazardous Substances Data: 852227-97-5(Hazardous Substances Data)

Usage

General Description

1-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine is a chemical compound that belongs to the class of piperidines. It is composed of a piperidine ring and a phenyl group that is substituted with a boron-containing heterocycle. The boron-containing heterocycle, known as 1,3,2-dioxaborolane, is a six-membered ring structure that contains boron, oxygen, and carbon atoms. The compound is commonly used in organic synthesis as a building block for various pharmaceuticals, agrochemicals, and materials. It is also known for its potential use in catalysis and as a precursor for the formation of carbon-carbon and carbon-heteroatom bonds in organic reactions.

InChI:InChI=1/C17H26BNO2/c1-16(2)17(3,4)21-18(20-16)14-9-8-10-15(13-14)19-11-6-5-7-12-19/h8-10,13H,5-7,11-12H2,1-4H3

Upstream product

• 84964-24-9 1-(3-bromophenyl)-piperidine 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1432450-88-8 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(3-(piperidin-1-yl)phenyl)quinazolin-4-amine 

Relevant articles and documents

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

Kinase scaffold repurposing for neglected disease drug discovery: Discovery of an efficacious, lapatanib-derived lead compound for trypanosomiasis

Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and require intravenous dosing, new drugs are needed. Initiating lead discovery campaigns b